Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New York Head & Neck Institute (NYHNI) is a specialized clinical and research center within Northwell Health, dedicated to the advanced treatment of disorders of the head, neck, and skull base. Founded in 2007 by Dr. Peter Costantino, the institute integrates multidisciplinary expertise in otolaryngology, neurosurgery, and oncology to manage complex conditions such as head and neck cancers, thyroid disease, and cranial base tumors. NYHNI is a leader in surgical innovation, particularly in transoral robotic surgery (TORS) and minimally invasive skull base procedures. Through its partnership with the Feinstein Institutes for Medical Research, the institute conducts cutting-edge clinical trials investigating novel therapeutics, including photoimmunotherapy and targeted biologics. The institute serves a diverse patient population across the New York metropolitan area, providing comprehensive care from diagnosis through reconstruction and rehabilitation. Its commitment to academic excellence is reflected in its robust residency programs and extensive portfolio of peer-reviewed research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New York Head & Neck Institute.